Latest news with #MarkFischer
Finextra
21-05-2025
- Business
- Finextra
Amplify adds Schwab's Mark Fischer COO
Amplify Platform ('Amplify'), a unified all-in-one wealth management platform for financial services, announced today it has hired Mark Fischer as the company's first chief operations officer (COO). Fischer joins Amplify's expanding C-suite roster as the firm continues its recent trajectory of record growth. 0 This content is provided by an external author without editing by Finextra. It expresses the views and opinions of the author. A financial services veteran with three decades of relevant experience, Fischer will lead Amplify's day-to-day operations with a strong focus on client success. In his new role, he will oversee relationship management, onboarding and training client service teams, and implementing strategies to scale operations and support the firm's continued growth. Fischer's extensive industry expertise will be instrumental in helping Amplify operate more efficiently, respond more effectively to client needs and deliver an enhanced, relationship-driven client experience. 'As we continue to build on the momentum of the past year, it's essential we have the necessary talent to effectively manage our growth and achieve our vision,' said Vickie Lewin, Chief Growth Officer. 'Mark has the experience and the passion we need in an operations leader. We're confident he will add significant value by deepening client engagement, ensuring seamless service delivery and driving initiatives that support client retention and accelerate our business development.' Prior to Amplify, Fischer served for more than a decade at Charles Schwab Asset Management, where he held COO and chief financial officer (CFO) roles. During his tenure, he led key operational and financial functions for the Schwab Asset Management platform, which has approximately $1.2 trillion in discretionary assets under management (AUM). Fischer also serves on the board of the Colorado chapter of the Alzheimer's Association. 'Amplify's recent growth has been impressive to watch,' remarked Fischer. 'But what impressed me even more is the obvious commitment to helping financial advisors work smarter, grow faster and prepare for the future with confidence. I look forward to helping elevate our operations to support that mission and consistently deliver exceptional value for our clients and partners.' Fischer, who received his undergraduate degree in business from the University of New Hampshire, Plymouth and his MBA from the University of Colorado, is the latest in a series of recent C-suite hires. Over the past year, the company has added veteran talent in the roles of chief financial officer, chief product officer, chief of staff and general counsel, as well as other key leadership hires. Since the beginning of 2024, Amplify has doubled its total employee headcount and reached more than $18 billion in total AUM. 'We remain focused on enhancing our platform and providing advisors with the tools they need to support better client outcomes,' added Aaron Brodt, Founder and CEO of Amplify. 'As we continue to evolve, our leadership team will be essential to our success. We're excited to welcome Mark aboard and can't wait to see his expertise in action, helping us deliver an industry-leading client experience and shape the next phase of Amplify's journey.'
Newsweek
07-05-2025
- Health
- Newsweek
Salsa Recall Update As FDA Issues Risk Warning Over Contamination Fears
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A salsa product recalled in April has now been issued a Class II risk classification by the U.S. Food and Drug Administration (FDA). MegaMex Foods LLC, based in California, issued a voluntary recall on April 14 for its La Victoria Cilantro Salsa as it may have been manufactured with cilantro contaminated with wood pieces. Newsweek has contacted MegaMex Foods for comment outside of regular working hours. A salsa product recalled in April due to the possible presence of wood has now been issued a Class II risk classification by the FDA. A salsa product recalled in April due to the possible presence of wood has now been issued a Class II risk classification by the FDA. Press Association/AP Why It Matters The product's potential contamination with foreign material poses a risk of dental injury or choking if consumed. The FDA's Class II risk classification refers to a situation in which "use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote." What To Know The affected product was distributed to nine consignees in California, Nevada, Oregon, Washington and Michigan. A total of 501 cases are affected by the recall and the product has a best-by date of December 2026. The product has a weight of 15.5 oz and can be identified by the UPC code: 0 72101 34470 3. The FDA issued its Class II risk classification for the product on May 6. What People Are Saying Dr. Mark Fischer, regional medical director at International SOS, told Newsweek previously: "It can be dangerous to consume metals or other foreign objects found in food... [They] can cause cuts or internal injury and may need to be removed via a surgical procedure. If you swallow any foreign objects, it's best to consult a healthcare professional." The FDA says in a report: "Hard or sharp foreign objects in food may cause traumatic injury including laceration and perforation of tissues of the mouth, tongue, throat, stomach and intestine as well as damage to the teeth and gums." What Happens Next The recall is still ongoing, according to the FDA. Consumers who have purchased the product are urged not to consume it. It should be discarded or returned to the place of purchase.
Yahoo
24-03-2025
- Health
- Yahoo
Dengue fever cases rising in popular spring break locations, CDC alerts
As spring breakers this season continue to head south into warmer territory, mosquitoes are posing a health risk that calls for extra attention. Global cases of dengue fever are on the rise, says the Centers for Disease Control and Prevention (CDC) — and it's warning of an uptick in U.S. travelers. The agency released a Health Alert Network advisory on March 18 noting that dengue activity and transmission "remain high" in some parts of the U.S. and globally, including the U.S. territories of Puerto Rico and the U.S. Virgin Islands. Dengue Fever: What You Need To Know About The Mosquito-borne Illness Sweeping Jamaica "Spring and summer travel coincide with the peak season for dengue in many countries, increasing the risk of both travel-associated and locally acquired cases in the United States," the CDC wrote. The CDC has marked dengue fever as a level 1 health alert, urging the public to "practice usual precautions." Read On The Fox News App This includes avoiding mosquito bites by using an EPA-registered insect repellent, wearing long-sleeved shirts and long pants when outdoors, and sleeping in a room that has air conditioning or screened windows. Many countries have reported a "higher-than-usual" number of dengue cases in 2024 and 2025, the CDC noted. Tiger Mosquitoes Blamed For Spread Of Dengue Fever: 'Most Invasive Species' The following countries have also reported higher-than-expected numbers of dengue cases among American travelers returning to U.S. soil: Brazil, Burkina Faso, Colombia, Cuba, Ecuador, Fiji, French Polynesia, Guadeloupe, Guatemala, Iran, Mexico, Pakistan, Panama, Philippines, Saint Lucia and Sudan. Dengue fever is a virus spread through bites from an infected mosquito. It is common in the Americas, Africa, the Middle East, Asia and the Pacific Islands, among other countries, according to the CDC. Travel Hot Spot Seeks Emergency Declaration Over Massive Bug Infestation In 2024, more than 13 million cases were reported in North, Central and South America, as well as in the Caribbean. Local transmission of these outbreaks was reported in California, Texas and Florida last year. Typical symptoms include aches and pains (in the eyes, muscles, joints, or bones), nausea, vomiting and rash — usually experienced within two weeks of being bitten. Most people experience symptoms for two to seven days before recovering. Click Here To Sign Up For Our Health Newsletter "It's typically a more mild illness, but can be severe, causing headaches, joint pain, fever, abdominal pain and even death," Dr. Mark Fischer, regional medical director of International SOS, a leading medical and security services company, previously told Fox News Digital. There is not currently any medication to treat dengue, according to the CDC. For more Health articles, visit Infected people are advised to rest, take acetaminophen for pain and fever, stay hydrated and see a doctor. There is a vaccine available for U.S. children between 9 and 16 years of age who have previously tested positive for dengue and are living in areas where the infection is common. Fox News Digital's Melissa Rudy contributed article source: Dengue fever cases rising in popular spring break locations, CDC alerts
Fox News
24-03-2025
- Health
- Fox News
Dengue fever cases rising in popular spring break locations, CDC alerts
As spring breakers this season continue to head south into warmer territory, mosquitoes are posing a health risk that calls for extra attention. Global cases of dengue fever are on the rise, says the Centers for Disease Control and Prevention (CDC) — and it's warning of an uptick in U.S. travelers. The agency released a Health Alert Network advisory on March 18 noting that dengue activity and transmission "remain high" in some parts of the U.S. and globally, including the U.S. territories of Puerto Rico and the U.S. Virgin Islands. "Spring and summer travel coincide with the peak season for dengue in many countries, increasing the risk of both travel-associated and locally acquired cases in the United States," the CDC wrote. The CDC has marked dengue fever as a level 1 health alert, urging the public to "practice usual precautions." This includes avoiding mosquito bites by using an EPA-registered insect repellent, wearing long-sleeved shirts and long pants when outdoors, and sleeping in a room that has air conditioning or screened windows. Many countries have reported a "higher-than-usual" number of dengue cases in 2024 and 2025, the CDC noted. The following countries have also reported higher-than-expected numbers of dengue cases among American travelers returning to U.S. soil: Brazil, Burkina Faso, Colombia, Cuba, Ecuador, Fiji, French Polynesia, Guadeloupe, Guatemala, Iran, Mexico, Pakistan, Panama, Philippines, Saint Lucia and Sudan. Dengue fever is a virus spread through bites from an infected mosquito. It is common in the Americas, Africa, the Middle East, Asia and the Pacific Islands, among other countries, according to the CDC. In 2024, more than 13 million cases were reported in North, Central and South America, as well as in the Caribbean. Local transmission of these outbreaks was reported in California, Texas and Florida last year. Typical symptoms include aches and pains (in the eyes, muscles, joints, or bones), nausea, vomiting and rash — usually experienced within two weeks of being bitten. Most people experience symptoms for two to seven days before recovering. "It's typically a more mild illness, but can be severe, causing headaches, joint pain, fever, abdominal pain and even death," Dr. Mark Fischer, regional medical director of International SOS, a leading medical and security services company, previously told Fox News Digital. There is not currently any medication to treat dengue, according to the CDC. For more Health articles, visit Infected people are advised to rest, take acetaminophen for pain and fever, stay hydrated and see a doctor. There is a vaccine available for U.S. children between 9 and 16 years of age who have previously tested positive for dengue and are living in areas where the infection is common. Fox News Digital's Melissa Rudy contributed reporting.
